reactive chemical long recognized as a potent respiratory sensitizer and irritant. 1, 14 Given its volatility, inhalation is a major exposure pathway. 14 Longitudinal studies of TDI-exposed workers have reported annual OA incidence of around 1% related to average airborne TDI concentrations less than 5 ppb. [15] [16] [17] [18] [19] In 2016, the American Conference of Governmental Industrial Hygienists (ACGIH) lowered its recommended 8 h
Threshold Limit Value Time Weighted Average (TLV-TWA) for TDI from 5.0 to 1.0 ppb. 20 The ACGIH recommendation was based primarily on a qualitative synthesis of human data, with supporting evidence from toxicologic studies, to protect against TDI respiratory sensitization. The current study extends this analysis using quantitative risk assessment methods to derive a set of alternative occupational exposure limits (OELs) on TDI inhalation exposure. These prospective OELs add to the body of information informing TDI risk management decisions.
| MATERIALS AND METHODS

| Database search strategy
The aim of the research was to combine existing epidemiologic data on the association between OA and TDI inhalation exposure for dose-response analyses supporting prospective OEL estimates. To construct the database, the English literature was searched for reports on epidemiologic studies of occupational asthma in TDI-exposed working populations that were published from January 1, 1950 to September 11, 2017 . The search was conducted using keyword searches of public domain citation databases (eg, PubMed, Medline, Embase, and Scopus), using terms such as: "toluene diisocyanate," "TDI," "occupational asthma," "work-related asthma," "asthmagen," "diisocyanate," "occupational exposure," "sensitization," "sensitizer," and others. Abstracts were reviewed to determine the applicability of articles under consideration. Citations within informative articles and reviews were also considered to uncover studies that may have been missed in database searches. Study authors were not contacted.
Studies judged suitable for dose-response analyses were those reporting data sufficient to estimate three key variables for doseresponse modeling: i) the number of potential OA incidence cases;
ii) the average TDI airborne exposure level over the observation period; and iii) the number of person-years at risk. In the absence of reported person-years (eg, cross-sectional data), estimates were derived from the population size and average employment duration.
Data sources were limited to study populations exposed to average TDI concentrations below 20 ppb. Greater average workplace concentrations may be indicative of poorer workplace conditions that may influence employment and increase the potential for selection bias. In addition, exposure to higher TDI levels may result in irritation symptoms that appear similar to those from low-dose sensitization; therefore, the potential for errors in case ascertainment is increased.
| Exposure
Data on the appropriate exposure index for dose-response modeling are uncertain. [21] [22] [23] It remains unclear whether TDI-induced asthma is a consequence of low cumulative exposure, exposure intensity, or some combination that also accounts for time ordering of intermittent exposure. "Cumulative exposure" is the product of intensity and duration, while "intensity" is measured as the time-weighted average TDI concentration or intermittent, peak exposure. [24] [25] [26] The current study uses intensity as the exposure metric because it is largely believed to be more relevant to the development of OA than cumulative exposure. 23 Average exposure is often used to describe exposure intensity in health-effect studies because time-specific data needed to assess peak exposures is generally lacking. 24 This was observed in existing TDI studies, which provided sparse information on the magnitude, time-order, and frequency of short-term exposures. For this study, it is assumed that the risk of TDI sensitization is related to average exposure, which may also be a correlate of peak exposures. 18, 21, 27 Where feasible, average TDI concentration values were abstracted precisely from study reports. Three eligible studies did not report average exposure directly, but sufficient data were available to estimate average TDI concentrations using either weighted averages (n = 2) or statistical methods assuming exposures were lognormally distributed.
Data on exposure modifiers, such as measurement techniques, control technology, and respiratory protection, were inconsistently reported; therefore, were not considered in exposure estimates.
| Statistical approach
Mathematical models were developed to estimate prospective OELs.
These OELs follow the two forms of health-and risk-based, as posited by the Scientific Committee on Occupational Exposure Limits.
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A "health-based" OEL is defined as an OEL that is applied to an agent that has an exposure level below which the excess risk of the adverse effect is considered negligible (ie, a threshold). Some agents may not have an exposure-response threshold; therefore, there is an associated risk for any exposure. In this case, a "risk-based" OEL can be derived under a condition of "target risk," which is a level of residual risk chosen to initiate risk management. For this study, the target risk was defined as an extra risk of one case per 1000 workers who are continuously exposed to TDI over a 45-year working lifetime. The health-based OEL used a standard benchmark dose approach and applied the EPA Benchmark Dose Software (BMDS), Version 2.6.0.1 (Build 88, June 15, 2015) . 29 Modeling for low-dose risk extrapolation was conducted by
Poisson regression using SAS software, Version 9.4 (2002 Version 9.4 ( -2012 were fitted to a suite of non-threshold binomial regression models, comprising: quantal-linear, log-probit, gamma, log-logistic, Weibull, probit, linear-quadratic (LQ), and logistic forms. Additionally, a nointercept LQ model was fit to examine the dose-response curve under an assumption that the data contained no background asthma cases. The adequacy of model fit was judged by likelihood goodness-of-fit using a critical value of 0.1. Reasonable agreement in estimates among the set of models suggested little model dependence; therefore, the "best" model was selected based on the minimum Akaike Information Criterion (AIC). 32 To account for sample variance, the 95% lower confidence limit on the average TDI concentration at the BMD (ie, BMDL) was selected as the PoD. The OEL was estimated by dividing the BMDL by an uncertainty factor to account for variation in human sensitivity (UF H ).
The default value UF H = 10 was used given disease severity and in lieu of specific information on human toxicokinetics or toxicodynamics. 33, 34 For low-dose extrapolation, general relative rate models were fit using Poisson regression. Two rate functions were assumed. First, a linear no-threshold (ie, LNT) response was assumed given its frequent use in risk assessment. The model follows the form: at unit dose. The variable λ 0 represents the baseline rate. The failure probability of OA conditional on τ and d is given by:
. Extra risk was calculated by:
. Similarly, models were fit assuming that the incidence rate was quadratic in dose, based on its superior fit among binomial models specified for the health-based OEL.
Heterogeneity in data among studies could substantively influence estimates. To account for heterogeneity, scaled residuals and plots of dose-response curves were examined for outlying data. Studies with scaled residuals >2.0 were considered outlying and effects on model estimates were examined by series removal of suspect studies. Final model estimates were obtained using study data excluding studies judged as outlying. In addition to removing outliers, leave-one-out analyses were conducted on the reduced set of studies to examine the influence of any one remaining study. Random effects models were also fit to examine heterogeneity and Poisson assumption validity.
Analyses were conducted using data restricted to: i) longitudinal studies to examine the effects of combining cross-sectional and longitudinal data; and ii) naïve populations to examine the potential for healthy worker selection effects. Naïve populations comprise workers who are first exposed at or after the beginning of observation in longitudinal studies, or time of survey for cross-sectional studies. To examine the effects from limiting exposure levels, models were fit that included the next available study with average exposure of 20 ppb or more.
3 | RESULTS
| Literature review
There were 29 reports providing information on the association between TDI exposure and OA. Of these, 13 lacked sufficient data for dose-response modeling and five were excluded for reporting average exposures ≥20 ppb (Supplementary through 1986 and data from this period was used in the current study. was worn frequently, but not always, when these short-term concentrations occurred. Data analyses were restricted to process workers known to be exposed (n = 946). The exposed group included 694 workers who could not be verified unexposed prior to enrollment. 36 About 70% of workers were employed at study facilities prior to observation. During the observation period, workers accrued 3874 person-years and 43 cases of respiratory sensitization were observed. There were seven cases reporting symptoms prior to observation that were excluded from the current study. Among 36 incidence cases, 9 (25%) presented only with minimal upper respiratory symptoms.
There were multiple reports from a longitudinal study following 277 U.S. TDI production workers from April 1973 to October 1978. 17, 38, 39 Information was mostly abstracted from the comprehensive report by Weill et al. 17 There were nine data collection visits made over the course of the study, during which 71 workers were "Inception" refers to the beginning of observation in longitudinal studies and time of survey for cross-sectional studies. "Survivors" are those workers who were actively employed and exposed prior to inception while "Naïve" refers to those workers first exposed at or after inception. b Case decision based on: i) self-reported symptoms; ii) decision rendered by occupational medicine clinician based on symptoms; and iii) OA diagnoses supported by one or more clinical tests (eg, pulmonary function, immunologic, and TDI challenge tests). These assessments were primarily based on symptomology (n = 13);
however, a single occurrence of symptoms was generally insufficient to diagnose OA. It was also noted that assessments might have and N-methylmorpholine were about 1.85 ppb (n = 12), 79 ppb (n = 7), and 7 ppm (n = 7), respectively.
Omae et al 41 conducted a cross-sectional study of 106 male workers employed in four TDI-producing plants (n = 87) and two research laboratories (n = 19) in Japan. 41 The average employment duration among these workers was 9 years. The time-at-risk was estimated as the product of study size and employment duration (954 person-years). Information on losses to followup was not available. Case definitions were unclear; however, six workers were found to be in "latent or subclinical states" of OA, which was 
| Statistical modeling
In fitting binomial models for BMD, none of the models met the goodness-of-fit criteria when using all study data (eg, P-values < 0.1 for all models). Inspection of the scaled residuals and dose-response plots Table S2 ). The fit of the no-intercept LQ was markedly improved without cross-sectional data, resulting in the fifth lowest AIC value.
The quadratic term remained negative but was no longer statistically BMDLs from all alternative models that met fit criteria (n = 58) ranged from 1.8 to 4.3 ppb, which was only slightly different from the range from the suite of models fit to all seven studies (2.3-4.1 ppb).
The first study excluded based on high average exposure was a cross-sectional examination of TDI production workers whose average exposure was 20.3 ppb. 43 Including these data resulted in a best-fit linear model with a statistically significant positive slope, (1.33 × 10 Annualized results from the Poisson excess relative rate models were essentially identical to those from corresponding binomial As before, the quadratic model provided a slightly better fit to the data. Table 4 .
| DISCUSSION
Using a BMD approach based on a synthesis of existing epidemiologic data, the estimated health-based OEL was equivalent to an 8 h TWA concentration of about 0.4 ppb, which is less than half that currently recommended by the ACGIH. This method assumed that keeping average workplace concentrations below this level is sufficient to avert sensitization. There is some evidence of a safe level corresponding to an average workplace TDI level that is ≤1 ppb. 37, 44 For example, there were no OA cases reported in the 12-year extended followup of 251 UK foam workers. 37 The average airborne TDI concentration during the observation period was less than 1 ppb, with only 1.3% of all 8 h bias. Third, the study was cross-sectional and prevalence is likely to be a poor proxy for OA incidence given sparse information on the observation period and evidence that nearly half (46%) of participants reported TDI exposure elsewhere. Fourth, OA cases were nearly twice as likely to present with dermal symptoms compared to non-cases, stemming from significant cutaneous exposure in production workers. 45 Given existing evidence of respiratory sensitization via skin contact, 14, 46, 47 
| Other risk assessments
Meredith et al 50 conducted a case-control study of workers employed in TDI manufacture and examined the dose-response using conditional logistic regression while treating exposure as a continuous variable.
Among cases (n = 27), the mean 8 h TWA exposure to TDI was 1. therefore, the adjusted benchmark toxicity value (for workers) was 2.5 ppb compared to 0.4 ppb in the current study. However, the NOAEL was comparable to the BMDL (4.3 ppb) in the current study, thus the disparity in OELs is attributable mainly to the differing UF H values used between the two studies. 
| Limitations
There are a number of noteworthy limitations. Another study weakness is the potential for selection bias from asthma or asthma symptoms that influence recruitment (selection in) and retention (selection out) of study participants. For example, crosssectional studies examine a population at a point in time; therefore, persons enrolled have survived to the time of survey and may represent a healthier group compared to all workers ever exposed. Longitudinal studies recruiting persons employed in TDI-jobs prior to cohort inception (ie, prevalent hires) may also be subject to this bias. 57, 58 The potential for these effects is reduced in study populations that are unexposed and disease free at the beginning of observation (ie, naïve participants), as in studies with cohort inception at plant startup. In studies enrolling survivors, the potential for selection effects can be examined by comparing risks between survivors and naïve participants. 
| CONCLUSIONS
TDI is a chemical in wide industrial use that is also a known respiratory sensitizer and irritant that is causally linked to OA. An appropriate characterization of the dose-risk relationship between TDI and OA is needed to manage worker risks. Previous examinations have reported on dose-response trends between TDI and OA; however, these analyses have been largely qualitative. 20, 27, 60 The current study used a quantitative approach to synthesize existing epidemiologic data and characterize the TDI-OA dose-response. Positive, but not statistically significant, dose-responses were observed in several models that allowed for estimates of candidate health and risk-based OELs. These prospective OELs were consistently below current recommendations.
For example, the ACGIH TLV-TWA for TDI is over twice that of the health-based OEL reported in the current study. This discordance is likely explained, at least in part, by differences in the qualitative approach used by ACGIH and the quantitative synthesis reported herein. Nevertheless, the available data were limited and risk estimates supporting prospective OELs were largely uncertain. This uncertainty should factor into decisions regarding the applicability of the OELs in risk management practices, which is beyond the scope of this report.
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